Author:
Chen Chang-gui,Yi Chun-feng,Chen Chang-fa,Tian Li-qun,Li Li-wei,Yang Li,Li Zuo-min,He Li-qun
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Chai T, Qiu C, Xian Z, et al. A narrative review of research advances in hypoxic pulmonary hypertension. Ann Transl Med, 2022,10(4):230
2. Li C, Zhu H, Zhang S, et al. Astragaloside IV ameliorates pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension by restraining the T follicular helper cell response and expanding T follicular regulatory cell response. Phytomedicine, 2022,102:154171
3. Rajagopal S, Yu YA. The Pathobiology of Pulmonary Arterial Hypertension. Cardiol Clin, 2022,40(1):1–12
4. Hu HH, Zhang RF, Dong LL, et al. Overexpression of ACE2 prevents hypoxia-induced pulmonary hypertension in rats by inhibiting proliferation and immigration of PASMCs. Eur Rev Med Pharmacol Sci, 2020,24(7):3968–3980
5. Liu Y, Nie X, Zhu J, et al. NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension. J Cell Mol Med, 2021,25(2):1221–1237
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献